相似文献/References:
[1]顾军,于泽平.乳腺癌内分泌治疗的困惑与展望[J].中华乳腺病杂志：电子版,2014,8(6):378.
[2]盛湲,李恒宇.从单细胞水平看肿瘤异质性[J].中华乳腺病杂志：电子版,2014,8(6):384.
[J].Chinese Journal of Breast Disease (Electronic Version),2014,8(4):384.
[3]路洪超,耿翠芝.BCAR1/p130Cas蛋白与乳腺癌抗雌激素药物耐药的相关研究[J].中华乳腺病杂志：电子版,2007,1(1):80.
LU Hong-chao,GEGN Cui-zhi.Association of BCAR1/p130Cas protein and breast cancer antiestrogen resistance[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):80.
[4]郭燕丽.乳腺肿块得超声诊断进展[J].中华乳腺病杂志：电子版,2007,1(2):42.
GUO Yan-li.Advancement of ultrasonic diagnosis in breast lump[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):42.
[5]纪光伟,黄安,吴峰.乳腺根治性活检术（附22例26次手术报告）[J].中华乳腺病杂志：电子版,2007,1(2):61.
JI Guang-wei,HUANG An,WU Feng.Radical biopsy of breast lump[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):61.
[6]张保宁,王仲照.国际早期乳腺癌研究进展：第10届圣·加仑乳腺癌会议报道[J].中华乳腺病杂志：电子版,2007,1(3):10.
ZHANG Bao-ning,WANG Zhong-zhao.Research advances in early breast cancer: a report of 10th St Gallen Breast Cancer Comference[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):10.
[7]付丽,郎荣刚.病理诊断在乳腺癌保乳手术中的作用[J].中华乳腺病杂志：电子版,2007,1(3):14.
FU Li,LANG Rong-gang.Role of pathological diagnosis on breast conserving surgery for breast cancer[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):14.
[8]王曦,杨名添,谢泽明.乳腺癌血清蛋白质芯片检测在预测乳腺癌预后中的应用[J].中华乳腺病杂志：电子版,2007,1(3):40.
WANG Xi,YANG Ming-tian,XIE Ze-ming.Proteome analysis for the identification of tumor-associated biomarkers to predict cancer prognosis[J].Chinese Journal of Breast Disease (Electronic Version),2007,1(4):40.
[9]孟令华,刘巍,宋丽楠.BCSG1、C erbB 2、VEGF表达与乳腺癌临床病理因素相关性研究[J].中华乳腺病杂志：电子版,2007,1(4):6.
[10]陈丽芬,路洪超,周军.家族性乳腺癌与散发性乳腺癌的临床生物学特性分析[J].中华乳腺病杂志：电子版,2007,1(4):10.
[11]张瑾,张晟.乳腺癌改良根治术后复发的治疗进展[J].中华乳腺病杂志：电子版,2010,4(1):8.
[12]张明迪,郑新宇.乳腺叶状肿瘤局部复发的临床风险因素分析[J].中华乳腺病杂志：电子版,2012,6(3):264.
[13]岳丰莉,潘沁汶,邓长容. 延长辅助内分泌治疗对比5 年标准治疗对雌激素受体阳性早期乳腺癌患者预后影响的Meta 分析[J].中华乳腺病杂志：电子版,2018,12(1):37.
[J].Chinese Journal of Breast Disease (Electronic Version),2018,12(4):37.